ghmpl | 20775
MPL p.W155 Mutation
Keywords:
Essentielle Thrombozytose
MPN
Myeloproliferative Neoplasie
PMF
Polyzythaemia vera
primäre Myelofibrose
Status
Material |
|
||
---|---|---|---|
Hint |
Next Generation Sequencing with Oncomine Myeloid Assay (Thermo Fisher), technical detection limit 5% (equivalent to 10% mutant nucleated cells). There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly. (see www.viollier.ch/en/SGMG_consent) |
||
Min. volume | 4 mL | ||
Stability |
Stability
2 days / 2-8°C
|
||
Duration | 1 week | ||
Frequency | 2 x per week | ||
Method | Next Generation Sequencing |
Price/Rate
Price |
Price
CHF 428.25
|
---|---|
Rate |
Rate
470.60 TP
|
Reference values
Value and unit | Age and unit | Sex |
---|---|---|
f+m |